<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02637310</url>
  </required_header>
  <id_info>
    <org_study_id>PMK-N02RS1_Phase 2B</org_study_id>
    <nct_id>NCT02637310</nct_id>
  </id_info>
  <brief_title>Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis</brief_title>
  <official_title>A Multi Center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of N02RS1 in Patients With Acute Bronchitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PharmaKing</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PharmaKing</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi center, randomized, double-blind, placebo-controlled, parallel, phase 2b clinical
      trial to evaluate the efficacy and safety of N02RS1 in patients with acute bronchitis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Suitable subjects randomized to the experimental or control group. The subjects eat IP during
      7days. Visit 3(3 days) evaluate BSS through phone call and visit 4(8 days) evaluate efficacy
      and safety.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BSS(Bronchitis Severity Score) score variation compared to baseline after 7 days</measure>
    <time_frame>Visit 1(-3days, screening), 2(0day, randomization), 3(3days), 4(8days)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Acute Bronchitis</condition>
  <arm_group>
    <arm_group_label>N02RS1 1200mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of Broussonetia spp and Lonicera spp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>sugar pill</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>N02RS1 1200mg</intervention_name>
    <description>1200mg/day, Three times a day orally, 2 tablets once, 7 days</description>
    <arm_group_label>N02RS1 1200mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1200mg/day, Three times a day orally, 2 tablets once, 7 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 19, under 75 of age

          -  Patients acute bronchitis, sputum symptoms, BSS over 7 points.

          -  Patients acute bronchitis within 7days.

          -  Non-pregnant, patients who agree to contraception.

          -  Patients who can write diary and available to communicate.

          -  Patients voluntarily agreed

        Exclusion Criteria:

          -  Patients with hypersensitivity to the drug.

          -  Patients who have gotten systemic steroid treatment within 4 weeks.

          -  Patients who have gotten treatment of antibiotics, bronchodilators, painkiller and
             secretagog within 7 days.

          -  Patients who have gotten treatment of mucus solvents or antitussives within 3 days.

          -  Patients who serious respiratory infections requiring antibiotic treatment, allergic
             bronchial asthma, bronchiectasis and chronic obstructive pulmonary disease.

          -  Patients heart disease, severe kidney, liver disease.

          -  The bleeding tendency or immunosuppressed patients.

          -  Patients with clinically significant abnormal values.

          -  Pregnant women or nursing mothers.

          -  Patients alcoholics or drug abuse.

          -  Patients taking other clinical trail's medicines within 30 days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2015</study_first_submitted>
  <study_first_submitted_qc>December 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2015</study_first_posted>
  <last_update_submitted>March 29, 2016</last_update_submitted>
  <last_update_submitted_qc>March 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Acute Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

